当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 利润表

华海药业

(600521)

  

流通市值:288.52亿  总市值:288.52亿
流通股本:14.97亿   总股本:14.97亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入4,516,353,788.972,368,563,881.429,547,425,412.47,247,654,219.7
  营业收入4,516,353,788.972,368,563,881.429,547,425,412.47,247,654,219.7
二、营业总成本4,001,688,219.952,002,446,656.27,978,739,192.175,940,775,917.63
  营业成本1,656,534,959.61834,236,299.543,636,604,438.412,705,990,778.14
  税金及附加58,902,417.8632,446,838.68116,829,397.5585,557,966
  销售费用945,364,975.35515,002,998.61,678,900,157.741,349,133,068.97
  管理费用720,107,570.65334,379,521.121,464,239,757.56991,085,356.96
  研发费用523,190,387.71238,907,980.88986,685,361.64687,452,738.14
  财务费用97,587,908.7747,473,017.3895,480,079.27121,556,009.42
  其中:利息费用116,299,888.0356,895,226.12219,800,151.74168,613,812.76
  其中:利息收入14,521,370.95,878,004.5753,215,053.5146,413,286.8
三、其他经营收益
  加:公允价值变动收益32,699,755.7813,253,728.51-69,493,156.45-51,794,785.91
  加:投资收益-12,094,720.76-8,001,842.97-28,719,824.06-22,389,423.24
  资产处置收益-14,072.93-14,072.932,333,721.9325,370.45
  资产减值损失(新)-54,290,859.75-19,483,656.25-122,874,355.27-34,678,626.25
  信用减值损失(新)-12,582,431.39-10,774,825.17-36,583,575.06-10,714,701.59
  其他收益72,872,005.2535,671,966.73157,439,567.77129,626,392.13
四、营业利润541,255,245.22376,768,523.141,470,788,599.091,316,952,527.66
  加:营业外收入9,974,467.76686,062.239,954,857.486,880,190.11
  减:营业外支出8,368,739.512,442,285.1317,134,981.6212,569,547.63
五、利润总额542,860,973.47375,012,300.241,463,608,474.951,311,263,170.14
  减:所得税费用137,702,111.9378,972,621.92356,145,358.12274,015,375.43
六、净利润405,158,861.54296,039,678.321,107,463,116.831,037,247,794.71
(一)按经营持续性分类
  持续经营净利润405,158,861.54296,039,678.321,107,463,116.831,037,247,794.71
(二)按所有权归属分类
  归属于母公司股东的净利润409,487,616.19297,404,077.751,118,981,177.611,031,268,135.45
  少数股东损益-4,328,754.65-1,364,399.43-11,518,060.785,979,659.26
  扣除非经常损益后的净利润363,424,637.01284,527,417.521,129,321,710.611,032,536,365.35
七、每股收益
  (一)基本每股收益0.280.210.770.71
  (二)稀释每股收益0.280.210.770.71
八、其他综合收益2,468,726.33739,654.29-110,875.97-6,120,263.49
  归属于母公司股东的其他综合收益2,434,094.49727,805.31-20,149.96-6,128,737.82
九、综合收益总额407,627,587.87296,779,332.611,107,352,240.861,031,127,531.22
  归属于母公司股东的综合收益总额411,921,710.68298,131,883.061,118,961,027.651,025,139,397.63
  归属于少数股东的综合收益总额-4,294,122.81-1,352,550.45-11,608,786.795,988,133.59
公告日期2025-08-262025-04-302025-04-302024-10-31
审计意见(境内)标准无保留意见
TOP↑